Although tirzepatide did not meet the criterion for superiority to dulaglutide with respect to the primary endpoint, a prespecified subgroup analysis suggested a possible lower incidence of death from any cause and of death from noncardiovascular causes in the tirzepatide group than in the dulaglutide group
At Allure Medical, we have two excellent treatments for banishing spider veins for good
Find articles by Wehrens, X
The method of administration (self-injection, oral, or topical), treatment duration, and dosage level all impact the total cost
On December 22, 2025 , the FDA approved the first oral GLP-1 medication specifically for obesity , the Wegovy pill from Novo Nordisk